We are live on ! Find out more
Jeff Yass

Jeff Yass Susquehanna International Group

AUM $1.26T Turnover 23.45%
1-Year Est. Return 41.03%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+1.48%
1 Year Est. Return
+41.03%
3 Year Est. Return
+173.37%
5 Year Est. Return
+166.23%
10 Year Est. Return
+509.07%
AUM
$1.26T
AUM Growth
-$27.4B
Cap. Flow
-$3.98B
Cap. Flow %
-0.32%
Top 10 Hldgs %
26.48%
Holding
15,103
New
1,828
Increased
5,364
Reduced
6,090
Closed
1,713
Avg Time Held Equity + Options
3.9 years
Top 10 Avg Time Held Equity + Options
4.7 years
Top 20 Avg Time Held Equity + Options
5.5 years
Avg Time Held Equity only
2.2 years
Top 10 Avg Time Held Equity only
1.6 years
Top 20 Avg Time Held Equity only
3.6 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 94.76%
2 Technology 2.14%
3 Communication Services 0.56%
4 Consumer Discretionary 0.56%
5 Healthcare 0.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HAE icon
8501
PUT
Haemonetics
HAE
$5.49B
$811K ﹤0.01%
7,700
-7,000
-48% -$651K
2023 Q4
11 quarters
HUSV icon
8502
First Trust Horizon Managed Volatility Domestic ETF
HUSV
$57M
$811K ﹤0.01%
20,954
-17,554
-46% -$711K
2024 Q1
10 quarters
AVMU icon
8503
Avantis Core Municipal Fixed Income ETF
AVMU
$168M
$810K ﹤0.01%
+18,970
New +$853K
2026 Q3
0 quarters
MFG icon
8504
Mizuho Financial
MFG
$118B
$810K ﹤0.01%
73,317
+14,336
+24% +$152K
2020 Q4
23 quarters
ASPN icon
8505
Aspen Aerogels
ASPN
$409M
$810K ﹤0.01%
147,805
-29,614
-17% -$155K
2020 Q4
23 quarters
AHR icon
8506
CALL
American Healthcare REIT
AHR
$13.4B
$810K ﹤0.01%
15,800
+5,100
+48% +$279K
2024 Q3
8 quarters
CLAR icon
8507
Clarus
CLAR
$194M
$810K ﹤0.01%
238,837
+70,060
+42% +$246K
2024 Q3
8 quarters
BHB icon
8508
Bar Harbor Bankshares
BHB
$684M
$810K ﹤0.01%
20,925
+11,368
+119% +$447K
2026 Q2
1 quarter
TENX icon
8509
Tenax Therapeutics
TENX
$66M
$809K ﹤0.01%
428,063
+138,899
+48% +$1.05M
2026 Q1
2 quarters
XDEC icon
8510
FT Vest US Equity Enhance & Moderate Buffer ETF December
XDEC
$206M
$808K ﹤0.01%
18,451
-43,671
-70% -$1.89M
2025 Q4
3 quarters
KNF icon
8511
Knife River
KNF
$3.04B
$808K ﹤0.01%
16,032
+10,302
+180% +$699K
2026 Q1
2 quarters
PK icon
8512
PUT
Park Hotels & Resorts
PK
$3.29B
$808K ﹤0.01%
52,400
-17,500
-25% -$263K
2017 Q1
38 quarters
CMPX icon
8513
Compass Therapeutics
CMPX
$104M
$807K ﹤0.01%
775,923
+467,628
+152% +$964K
2024 Q2
9 quarters
PLMR icon
8514
Palomar
PLMR
$4.17B
$807K ﹤0.01%
6,544
-4,200
-39% -$561K
2026 Q1
2 quarters
CTNM icon
8515
PUT
Contineum Therapeutics
CTNM
$369M
$807K ﹤0.01%
+60,100
New +$896K
2026 Q3
0 quarters
RYN icon
8516
CALL
Rayonier
RYN
$6.24B
$806K ﹤0.01%
43,900
-12,900
-23% -$270K
2019 Q1
30 quarters
TII icon
8517
Titan Mining
TII
$153M
$806K ﹤0.01%
314,739
+203,532
+183% +$519K
2026 Q2
1 quarter
NEA icon
8518
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$2.99B
$805K ﹤0.01%
80,924
-2,259
-3% -$25.1K
2025 Q4
3 quarters
JBIO icon
8519
PUT
Jade Biosciences
JBIO
$957M
$805K ﹤0.01%
57,300
-11,000
-16% -$221K
2024 Q2
9 quarters
ADNT icon
8520
CALL
Adient
ADNT
$1.13B
$805K ﹤0.01%
47,800
-18,000
-27% -$347K
2024 Q4
7 quarters
TFIN icon
8521
Triumph Financial
TFIN
$1.39B
$804K ﹤0.01%
13,399
-9,607
-42% -$698K
2020 Q3
24 quarters
CWST icon
8522
PUT
Casella Waste Systems
CWST
$6.35B
$804K ﹤0.01%
+10,000
New +$914K
2026 Q3
0 quarters
GOLY icon
8523
Strategy Shares Gold Enhanced Yield ETF
GOLY
$62.6M
$803K ﹤0.01%
33,098
-11,919
-26% -$309K
2026 Q2
1 quarter
ARCB icon
8524
CALL
ArcBest
ARCB
$2.95B
$803K ﹤0.01%
6,300
-1,600
-20% -$225K
2021 Q1
22 quarters
MEIB icon
8525
Direxion META Defined Income Boost ETF
MEIB
$1.97M
$802K ﹤0.01%
+26,991
New +$701K
2026 Q3
0 quarters

Similar funds

Jeff Yass's Q3 2026 Portfolio in Review

As of Q3 2026, Jeff Yass held 15,103 positions worth $1.26T, down 2.1% from $1.28T the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Jeff Yass's Q3 2026 filing shows 1,828 new, 5,364 increased, 6,090 reduced and 1,713 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 4,178,565 shares worth $405M. The largest sale was Microsoft, an estimated $2.88B.

By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, up from 94% a quarter earlier, followed by Technology and Communication Services.

  • Jeff Yass's largest Q3 2026 buy was iShares Core MSCI EAFE ETF: 4,178,565 shares worth $405M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2026, an estimated $4.73B increase.
  • Jeff Yass's biggest Q3 2026 reduction was Microsoft, cutting an estimated $2.88B.
  • Jeff Yass fully exited Capital Group Growth ETF in Q3 2026, selling an estimated $279M.
  • Jeff Yass's ten largest holdings make up 26% of its $1.26T portfolio in Q3 2026.
  • Jeff Yass opened 1,828 new positions and closed 1,713 in Q3 2026.
  • Jeff Yass's portfolio value fell 2.1% quarter-over-quarter to $1.26T.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.